9 assets in Appendix Adenocarcinoma

Therapeutic assets addressing Appendix Adenocarcinoma, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Irinotecan Appendix Adenocarcinoma	City of Hope Medical Center	P3	BB (66)
Fluorouracilum Appendix Adenocarcinoma	City of Hope Medical Center	P3	BB (64)
Muamycin Appendix Adenocarcinoma	City of Hope Medical Center	P3	B (63)
Atezolizumab Appendix Adenocarcinoma	M.D. Anderson Cancer Center	P2	CCC (53)
Apl-5125 Appendix Adenocarcinoma	Apollo Therapeutics Ltd	P1/2	CCC (48)
Acm-Cpg Appendix Adenocarcinoma	Brown University	P1	CC (43)
Adriamycin Appendix Adenocarcinoma	City of Hope Medical Center	P1	CC (43)
Cis-Diamminedichloroplatinum Ii Appendix Adenocarcinoma	City of Hope Medical Center	P1	CC (43)
Oxaliplatin Appendix Adenocarcinoma	City of Hope Medical Center	P1	CC (43)